The tTF-CREKA molecule is hypothesized to have self-amplifying thrombogenesis due to its ability to recognize both original microthrombi complexes present at degenerative tumor sites, as well as recognize new clotting-associated fibronectin-fibrin complexes which form as the first coaguligands bind. The gene discussed is FN1; the disease is neoplasm.